Cyclooxygenase

• Cyclooxygenase (COX) is an enzyme involved in the synthesis of prostanoids, including prostaglandins, prostacyclin, and thromboxanes. It plays a crucial role in inflammation, pain, and various physiological processes in the body.
• There are two main isoforms of cyclooxygenase: COX-1 and COX-2.

File:Prostaglandin synthesis.svg

Prostaglandin synthesis, involving the action of cyclooxygenase.

Cyclooxygenase

Error creating thumbnail:

Cyclooxygenase-2

Error creating thumbnail:

Cyclooxygenase inhibitors

COX-1

• COX-1 is constitutively expressed in most tissues and has various physiological functions, including:
• Gastroprotection: COX-1-derived prostaglandins help maintain the integrity of the stomach lining by promoting mucus production and reducing acid secretion.
• Renal Function: COX-1 plays a role in maintaining renal blood flow and regulating sodium and water balance.
• Platelet Aggregation: COX-1-derived thromboxane A2 promotes platelet aggregation and blood clot formation.
• COX-1 is considered a housekeeping enzyme, responsible for the normal physiological functions mentioned above.

COX-2

• COX-2, in contrast to COX-1, is an inducible enzyme and is primarily expressed in response to inflammation and certain pathological conditions.
• It is responsible for the production of prostaglandins and other prostanoids that are involved in inflammation, pain, and other immune responses.

Functions of COX-2 include:

• Inflammation: COX-2-derived prostaglandins mediate the inflammatory response by promoting vasodilation, increased vascular permeability, and recruitment of immune cells to the site of inflammation.
• Pain and Fever: COX-2-derived prostaglandins sensitize pain receptors, contributing to the perception of pain. Additionally, they play a role in the hypothalamic regulation of body temperature, leading to fever.
• Cellular Proliferation: COX-2 expression is associated with cell proliferation and tissue remodeling. It is involved in processes such as wound healing and tissue repair.

• The inducible nature of COX-2 makes it a target for therapeutic intervention in conditions characterized by inflammation and pain.

Mechanism of Action

• The mechanism of action of cyclooxygenase involves the conversion of arachidonic acid, a fatty acid derived from cell membrane phospholipids, into prostaglandin H2 (PGH2), which serves as the precursor for various prostanoids.

This process occurs in several steps:

• Arachidonic Acid Release: In response to cellular signaling, phospholipases are activated, leading to the release of arachidonic acid from cell membrane phospholipids.
• Cyclooxygenase Activity: The released arachidonic acid is then converted by cyclooxygenase into prostaglandin G2 (PGG2). This step involves the incorporation of two oxygen molecules into arachidonic acid.
• Peroxidase Activity: The PGG2 produced by cyclooxygenase undergoes further transformation by the peroxidase activity of cyclooxygenase, resulting in the formation of prostaglandin H2 (PGH2).
• Prostanoid Synthesis: Prostaglandin H2 (PGH2) serves as the precursor for various prostanoids, including prostaglandins, prostacyclin, and thromboxanes. Additional enzymes in the cells then convert PGH2 into specific prostanoids, each with its own biological effects.

• The prostanoids synthesized from the action of cyclooxygenase play crucial roles in mediating inflammation, pain, and other physiological processes in the body.

Inhibition of COX

• The therapeutic potential of inhibiting cyclooxygenase lies in modulating the synthesis of prostanoids.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of medications that inhibit COX activity.

They can be categorized into two types:

• Nonselective COX inhibitors: These drugs inhibit both COX-1 and COX-2. Examples include aspirin, ibuprofen, and naproxen. Nonselective COX inhibitors have analgesic, anti-inflammatory, and antipyretic effects but may also cause gastrointestinal side effects and affect platelet function.
• Selective COX-2 inhibitors: These drugs specifically target COX-2 while sparing COX-1. Examples include celecoxib and rofecoxib. Selective COX-2 inhibitors provide anti-inflammatory and analgesic effects with potentially fewer gastrointestinal side effects but have been associated with an increased risk of cardiovascular events.
• The inhibition of COX activity by NSAIDs reduces the production of prostanoids, leading to decreased inflammation, pain relief, and other therapeutic effects. However, it is important to consider the potential side effects and individual patient factors when using these medications.

Cyclooxygenase Resources
Latest articles Most recent articles Ongoing trials	Wikipedia